Addus HomeCare (NASDAQ:ADUS) EVP Sells 7,141 Shares of Company Stock

Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) EVP Michael Wattenbarger sold 7,141 shares of the firm’s stock in a transaction on Friday, November 6th. The shares were sold at an average price of $124.67, for a total value of $890,268.47. Following the completion of the sale, the executive vice president owned 7,303 shares in the company, valued at $910,465.01. The trade was a 49.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Addus HomeCare Stock Performance

Shares of ADUS traded up $3.87 during midday trading on Tuesday, hitting $126.29. 225,844 shares of the stock traded hands, compared to its average volume of 237,872. The business’s 50 day moving average price is $117.74 and its two-hundred day moving average price is $106.95. The firm has a market capitalization of $2.36 billion, a PE ratio of 21.05, a price-to-earnings-growth ratio of 1.82 and a beta of 0.75. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.69 and a current ratio of 1.64. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $131.59.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. The business had revenue of $387.74 million for the quarter, compared to analysts’ expectations of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.56 EPS. Equities research analysts predict that Addus HomeCare Corporation will post 6.34 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Raymond James Financial set a $137.00 price target on shares of Addus HomeCare in a research note on Monday, September 28th. Weiss Ratings upgraded Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, September 24th. Barclays increased their price objective on Addus HomeCare from $96.00 to $101.00 and gave the stock an “underweight” rating in a report on Wednesday, November 4th. Wall Street Zen upgraded Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Finally, UBS Group lifted their target price on Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. Seven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $134.70.

Check Out Our Latest Report on Addus HomeCare

Hedge Funds Weigh In On Addus HomeCare

Institutional investors and hedge funds have recently bought and sold shares of the stock. NFJ Investment Group LLC acquired a new position in Addus HomeCare during the 2nd quarter valued at about $29,000. Heritage Family Offices LLP acquired a new stake in shares of Addus HomeCare in the 3rd quarter worth approximately $43,000. Parallel Advisors LLC lifted its stake in shares of Addus HomeCare by 66.3% in the 1st quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock worth $38,000 after acquiring an additional 161 shares during the period. Hantz Financial Services Inc. lifted its stake in shares of Addus HomeCare by 21.3% in the 3rd quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock worth $69,000 after acquiring an additional 109 shares during the period. Finally, Nisa Investment Advisors LLC boosted its holdings in shares of Addus HomeCare by 16.9% in the third quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock valued at $85,000 after acquiring an additional 111 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

Further Reading

Insider Buying and Selling by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.